US 10508083
Substituted piperidine compound and use thereof
granted A61PA61P25/00
Quick answer
US patent 10508083 (Substituted piperidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P25/00